EAM
VSTM icon

Exome Asset Management’s Verastem VSTM Stock Holding History

Exome Asset Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Sell
429,041
-207,659
-33% -$1M 1.01% 38
2026
Q1 		$3.37M Buy
636,700
+234,957
+58% +$1.45M 1.75% 22
2025
Q4 		$3.1M Buy
+401,743
New +$3.58M 1.48% 29
2025
Q3 		– Sell
-599,900
Closed -$2.49M – 96
2025
Q2 		$2.49M Buy
+599,900
New +$3.76M 1.85% 20

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Exome Asset Management's VSTM Position: Q2 2026 in Review

Exome Asset Management reduced its Verastem (VSTM) stake by 33% in Q2 2026, selling an estimated $1M and leaving 429,041 shares worth $1.64M. The position accounts for 1.01% of the portfolio, ranked #38.

Exome Asset Management first reported a position in VSTM in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.37M in Q1 2026. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Exome Asset Management held 429,041 shares of Verastem worth $1.64M as of Q2 2026.
  • Exome Asset Management sold 207,659 Verastem shares in Q2 2026, an estimated $1M.
  • Verastem made up 1.01% of Exome Asset Management's portfolio in Q2 2026, its #38 holding.
  • Exome Asset Management first reported a position in Verastem in Q2 2025 and has held it in 4 quarters since.
  • Exome Asset Management's Verastem position peaked at $3.37M in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Exome Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.